CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Capsules From CROI 2017

Richard Jefferys analyzes key presentations from this year's Conference on Retroviruses and Opportunistic Infections.

By Richard Jefferys for Treatment Action Group

HIV Researchers Reassert Treatment Is Prevention

"We need to meet people where they are at. If you do not want to have a medical provider, but you are interested in being on [pre-exposure prophylaxis], then we should create an environment where it is possible for you to get that," says Matthew Gold...

By Barbara Jungwirth

U.S. Travel Ban Would Be Detrimental to Scientific Research

"Infectious disease -- HIV, Ebola, Zika -- does not know borders," says Wendy Armstrong, M.D., chair of the HIV Medicine Association (HIVMA) board of directors.

By Barbara Jungwirth

Two-Drug HIV Treatment Regimens Effective in Latest Studies

"This is really the first step in demonstrating that two-drug regimens can be as effective as three-drug regimens," says Kimberly Smith, M.D., M.P.H.

By Barbara Jungwirth

Early Diagnosis and Treatment in Infants Is Challenging

"Even if we have the best drug, it cannot do anything if we don't have all [the social] aspects together," says Bindiya Meggi, M.Sc.

By Barbara Jungwirth

The Company You Keep: Do Social Networks Influence HIV Status?

Social networks are a big part of life and offer a community of support. But could they also play a role in HIV status?

By Heather Boerner

Incidence of All Cancers but Lung Cancer Drops After HIV Group Stops Smoking

Incidence of all cancers combined fell in the years after HIV-positive people stopped smoking, according to results of a nine-year 35,424-person analysis.

By Mark Mascolini

Higher Bilirubin Linked to Lower Cardiovascular Disease Risk Regardless of HIV

Higher total bilirubin predicted incident cardiovascular disease in an analysis of 98,405 U.S. veterans with or without HIV infection.

By Mark Mascolini

Governmental Bodies Must Become More Flexible in Promoting HIV Prevention

"The line between government interests and community interests is completely fuzzy in the HIV universe," says Demetre Daskalakis, M.D., M.P.H.

By Barbara Jungwirth

Communities Affected by HIV Must Have a Voice in Clinical Research

"Look for women mentors and make use of the spaces we have created for you," says Morenike Ukpong-Folayan.

By Barbara Jungwirth